| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5683186 | Progrès en Urologie | 2016 | 20 Pages |
Abstract
Application of appropriate indication for transplantectomy relies on benefit-risk balance between the interruption of immunosuppressive agents versus survival and quality of life impairment after returning to dialysis. No robust recommendation exists regarding switch of immunosuppressive drugs. Cancer predictive factors and access to a subsequent transplantation are key decisive elements.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
F. Kleinclauss, R. Thuret, T. Murez, M.O. Timsit,